全文获取类型
收费全文 | 5083篇 |
免费 | 312篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 225篇 |
妇产科学 | 200篇 |
基础医学 | 556篇 |
口腔科学 | 83篇 |
临床医学 | 422篇 |
内科学 | 1206篇 |
皮肤病学 | 41篇 |
神经病学 | 640篇 |
特种医学 | 450篇 |
外科学 | 377篇 |
综合类 | 76篇 |
一般理论 | 4篇 |
预防医学 | 501篇 |
眼科学 | 53篇 |
药学 | 279篇 |
中国医学 | 9篇 |
肿瘤学 | 268篇 |
出版年
2022年 | 23篇 |
2021年 | 46篇 |
2020年 | 33篇 |
2019年 | 66篇 |
2018年 | 102篇 |
2017年 | 89篇 |
2016年 | 86篇 |
2015年 | 103篇 |
2014年 | 132篇 |
2013年 | 236篇 |
2012年 | 253篇 |
2011年 | 256篇 |
2010年 | 147篇 |
2009年 | 179篇 |
2008年 | 239篇 |
2007年 | 240篇 |
2006年 | 225篇 |
2005年 | 237篇 |
2004年 | 209篇 |
2003年 | 208篇 |
2002年 | 159篇 |
2001年 | 157篇 |
2000年 | 154篇 |
1999年 | 118篇 |
1998年 | 121篇 |
1997年 | 91篇 |
1996年 | 104篇 |
1995年 | 82篇 |
1994年 | 77篇 |
1993年 | 85篇 |
1992年 | 96篇 |
1991年 | 80篇 |
1990年 | 86篇 |
1989年 | 117篇 |
1988年 | 103篇 |
1987年 | 85篇 |
1986年 | 72篇 |
1985年 | 72篇 |
1984年 | 61篇 |
1983年 | 42篇 |
1982年 | 34篇 |
1981年 | 38篇 |
1980年 | 27篇 |
1979年 | 34篇 |
1978年 | 21篇 |
1977年 | 27篇 |
1976年 | 20篇 |
1975年 | 36篇 |
1974年 | 15篇 |
1973年 | 11篇 |
排序方式: 共有5410条查询结果,搜索用时 0 毫秒
81.
Serial evaluations of lymphocytotoxic antibody (LCTAb) and responsiveness to random donor platelet transfusion were reviewed in 234 patients who had developed LCTAb at some time during their treatment course. Seventy (30%) of these patients had significant falls in antibody levels. In 44 patients these declines occurred after further antigenic exposure was reduced either because no transfusions were administered or only histocompatible platelets were transfused. Forty patients with declines in LCTAb levels who were previously refractory to platelet transfusion were rechallenged with random donor platelets. Thirty-four of 35 clinically evaluable patients had good responses to these unmatched transfusions for 2 weeks to 36 months, and in 21 patients antibody did not return despite repeated transfusions. Thus, serial LCTAb measurements are helpful in the management of alloimmunized patients. Many patients will have decreases or a loss of LCTAb, either permanently or transiently, and can be successfully supported with more easily available unmatched random donor platelet transfusions. 相似文献
82.
R.J. van de Peppel M.T. van der Beek L.G. Visser M.G.J. de Boer J. Wallinga 《International journal of antimicrobial agents》2019,53(3):284-293
Objectives
Triazole resistance in Aspergillus spp. is emerging and complicates prophylaxis and treatment of invasive aspergillosis (IA) worldwide. New polymerase chain reaction (PCR) tests on broncho-alveolar lavage (BAL) fluid allow for detection of triazole resistance at a genetic level, which has opened up new possibilities for targeted therapy. In the absence of clinical trials, a modelling study delivers estimates of the added value of resistance detection with PCR, and which empiric therapy would be optimal when local resistance rates are known.Design
A decision-analytic modelling study was performed based on epidemiological data of IA, extended with estimated dynamics of resistance rates and treatment effectiveness. Six clinical strategies were compared that differ in use of PCR diagnostics (used vs not used) and in empiric therapeutic choice in case of unknown triazole susceptibility: voriconazole, liposomal amphotericin B (LAmB) or both. Outcome measures were proportion of correct treatment, survival and serious adverse events.Results
Implementing aspergillus PCR tests was projected to result in residual treatment-susceptibility mismatches of <5% for a triazole resistance rate up to 20% (using voriconazole). Empiric LAmB outperformed voriconazole at resistance rates >5–20%, depending on PCR use and estimated survival benefits of voriconazole over LAmB. Combination therapy of voriconazole and LAmB performed best at all resistance rates, but the advantage over the other strategies should be weighed against the expected increased number of drug-related serious adverse events. The advantage of combination therapy over LAmB monotherapy became smaller at higher triazole resistance rates.Conclusions
Introduction of current aspergillus PCR tests on BAL fluid is an effective way to increase the proportion of patients that receive targeted therapy for IA. The results indicate that close monitoring of background resistance rates and adverse drug events are important to attain the potential benefits of LAmB. The choice of strategy ultimately depends on the probability of triazole resistance, the availability of PCR and individual patient characteristics. 相似文献83.
84.
Biologic basis for interleukin-1 in disease 总被引:164,自引:6,他引:164
To understand the role of the proinflammatory cytokine interleukin-1 (IL-1) in disease, investigators have studied how production of the different members of the IL-1 family is controlled, the various biologic activities of IL-1, the distinct and various functions of the IL-1 receptor (IL-1R) family, and the complexity of intracellular signaling. Mice deficient in IL-1Beta, IL-1Beta converting enzyme, and IL-1R type I have also been studied. Humans have been injected with IL- 1 (either IL-1alpha or IL-1beta) for enhancing bone marrow recovery and for cancer treatment. The IL-1-specific receptor antagonist (IL-1Ra) has also been tested in clinical trials. The topics discussed in this review include production and activities of IL-1 and IL-1Ra molecules, the effects of IL-1 on gene expression, functions of cell-bound and soluble IL-1 receptors, the importance of the IL-1R accessory protein, newly discovered signal transduction pathways, naturally occurring cytokines limiting IL-1 production or activity, the effects of blocking cyclooxygenase and nitric oxide, and the outcomes of IL-1 and IL-1 Ra in human trials. Special attention is paid to IL-1beta converting enzyme and programmed cell death. The roles of IL-1 in hematopoiesis, leukemia, atherosclerosis, and growth of solid tumors are also discussed. This is a lengthy review, with 586 citations chosen to illustrate specific areas of interest rather than a compendium of references. At the end of each section, a short commentary summarizes what the author considers established or controversial topics linking the biology of IL-1 to mechanisms of disease. 相似文献
85.
86.
87.
Zampieron A Harrington M Elseviers M Lindley E De Vos JY Visser R 《EDTNA/ERCA journal (English ed.)》2004,30(2):59-61
The Research Board (RB) of EDTNA/ERCA is a multidisciplinary group, established by the participation of renal care centres all around Europe. The RB also works with the association's Special Interest Groups (SIGs) on developing guidelines for implementing safe renal clinical practice. It is composed of six permanent members, with co-opted experts from specific fields. This article describes how the RB works and the projects implemented since 1996. 相似文献
88.
Zampieron A Jayasekera H Elseviers M Lindley E De Vos JY Visser R Harrington M 《EDTNA/ERCA journal (English ed.)》2004,30(2):84-90
Haemodialysis patients are known to be at risk of infection of Hepatitis C Virus (HCV) through nosocomial spread. This paper presents the first part of a study on epidemiology and management of HCV, in a haemodialysis population, conducted by the EDTNA/ERCA Research Board. Data on HCV management and infection control procedures was collected from 136 European centres using an electronic questionnaire. The study identifies a number of possible risk factors for transmission of the virus: failing to disinfect devices between patients, sharing of single-use vials to prepare drugs or infusions for different patients, inadequate sterilisation or cleaning of machines between dialysis sessions, unsatisfactory environmental cleaning and distance less than one metre between chairs. 相似文献
89.
90.
A procedure for the continuous flow incubation of isolated adrenal cells is described. In this way the advantages of continuous flow incubations of adrenal tissue are combined with those of isolated adrenal cells. Suspensions of isolated adrenal cells were prepared by a modification of the collagenase method. A sigmoid dose-response curve was obtained when these cells were incubated with ACTH in batch incubations. Under these conditions (in the presence of 1 mU ACTH/ml) the corticosterone production rate remained constant during at least 240 min. This production rate was linearly related to the number of cells. Pre-incubation of the cells during 3 h resulted in an increased response to ACTH. In continuous flow incubations without ACTH the corticosterone production was negligible. With 100 mu U ACTH/ml corticosterone production increased sharply after a short lag period. A maximum was reached after 60-75 min followed by a slow decrease. Cells pre-incubated in the continuous flow apparatus had a slightly diminished ACTH response without loss of affinity to ACTH. The continuous flow incubation of isolated adrenal cells offers new possibilities for the dynamic study of steroid biosynthesis in vitro. The method may also be valuable to study processes in a wide variety of other tissues. 相似文献